What is NDC 64980-278?

64980-278 is the product NDC for Lithium Carbonate, Lithium carbonate 450 mg/1 tablet, extended release, listed with the FDA by Rising Pharma Holdings, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lithium Carbonate?

61 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lithium Carbonate NDC 64980-278 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)64980-278Labeler and product segments. Claims need a package NDC.

Product NDC at billing width64980-0278Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
64980-278-01	64980027801	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-278-01)Marketed from Mar 1, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lithium Carbonate
Generic name (nonproprietary): lithium carbonate
Active ingredients: Lithium carbonate — 450 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Rising Pharma Holdings, Inc.NDC labeler code 64980
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205663
Marketing start: Mar 1, 2018
Listing expires: Dec 31, 2026
Identifiers: Product ID 64980-278_c2afa358-e66b-48aa-8c51-79b55ac31016SPL ID c2afa358-e66b-48aa-8c51-79b55ac31016SPL set ID 5e18d105-662d-4729-aa81-00be7472addeRxCUI 197892UNII 2BMD2GNA4V
Pharmacologic class: Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N464980027801 followed by a unit qualifier and the quantity

Package 64980-0278-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 16, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Lithium Carbonate Extended-Release Tablets is indicated in the treatment of manic episodes of manic-depressive illness. Maintenance therapy prevents or diminishes the intensity of subsequent episodes in those manic-depressive patients with a history of mania. Typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, elation, poor judgment, aggressiveness and possibly hostility. When given to a patient experiencing a manic episode, Lithium Carbonate Extended-Release Tablets may produce a normalization of symptomatology within 1 to 3 weeks.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 64980-278

What is NDC 64980-278?: 64980-278 is the product NDC for Lithium Carbonate, Lithium carbonate 450 mg/1 tablet, extended release, listed with the FDA by Rising Pharma Holdings, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lithium Carbonate.
What is the active ingredient?: Lithium carbonate.
Who is the labeler?: Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lithium Carbonate?: 61 other product NDCs are listed under this name. See all Lithium Carbonate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lithium Carbonate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lithium Carbonate	Lithium carbonate 300 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0886	00054-0886-2500054-0886-31
Lithium Carbonate	Lithium carbonate 150 mg/1	Capsule, Gelatin coatedOral	Hikma Pharmaceuticals USA Inc.	0054-0887	00054-0887-25
Lithium Carbonate	Lithium carbonate 300 mg/1	Capsule, Gelatin coatedOral	Hikma Pharmaceuticals USA Inc.	0054-0890	00054-0890-2500054-0890-31
Lithium Carbonate	Lithium carbonate 600 mg/1	Capsule, Gelatin coatedOral	Hikma Pharmaceuticals USA Inc.	0054-0891	00054-0891-25
lithium carbonate	Lithium carbonate 150 mg/1	CapsuleOral	Coupler LLC	67046-1690	67046-1690-03
Lithium Carbonate	Lithium carbonate 450 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4678	70518-4678-00
Lithium Carbonate	Lithium carbonate 600 mg/1	CapsuleOral	American Health Packaging	60687-964	60687-0964-21
Lithium Carbonate	Lithium carbonate 150 mg/1	CapsuleOral	Coupler LLC	67046-0547	67046-0547-03
lithium carbonate	Lithium carbonate 150 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4627	70518-4627-00
Lithium Carbonate	Lithium carbonate 300 mg/1	Tablet, Film coated, Extended releaseOral	Coupler LLC	67046-1575	67046-1575-03

All 62 Lithium Carbonate NDCs

Other NDCs under ANDA 205663

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205663
Product	Strength	Form · route	Labeler	Product NDC
Lithium Carbonate	Lithium carbonate 450 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-2086